Report cover image

Global Ertapenem Sodium for Injection Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 108 Pages
SKU # APRC20102826

Description

Summary

According to APO Research, The global Ertapenem Sodium for Injection market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Ertapenem Sodium for Injection include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Unitech Biotech, Par Pharmaceutical, NorthStar Rx and Intelicure Lifesciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ertapenem Sodium for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ertapenem Sodium for Injection.

The Ertapenem Sodium for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ertapenem Sodium for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Ertapenem Sodium for Injection Segment by Company

Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
Sichuan Pharmaceutical Preparation Co., Ltd.
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Qilu Anti Pharmaceutical Co., Ltd.
Hainan Herui Pharmaceutical Co., Ltd.
Unitech Biotech
Par Pharmaceutical
NorthStar Rx
Intelicure Lifesciences
EUGIA PHARMA INC
ACS DOBFAR SPA

Ertapenem Sodium for Injection Segment by Type

0.5g
1g

Ertapenem Sodium for Injection Segment by Application

Hospital
Clinic
Other

Ertapenem Sodium for Injection Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Sodium for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ertapenem Sodium for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Ertapenem Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

108 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Ertapenem Sodium for Injection Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Ertapenem Sodium for Injection Sales Estimates and Forecasts (2020-2031)
1.3 Ertapenem Sodium for Injection Market by Type
1.3.1 0.5g
1.3.2 1g
1.4 Global Ertapenem Sodium for Injection Market Size by Type
1.4.1 Global Ertapenem Sodium for Injection Market Size Overview by Type (2020-2031)
1.4.2 Global Ertapenem Sodium for Injection Historic Market Size Review by Type (2020-2025)
1.4.3 Global Ertapenem Sodium for Injection Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Ertapenem Sodium for Injection Sales Breakdown by Type (2020-2025)
1.5.2 Europe Ertapenem Sodium for Injection Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Ertapenem Sodium for Injection Sales Breakdown by Type (2020-2025)
1.5.4 South America Ertapenem Sodium for Injection Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Ertapenem Sodium for Injection Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Ertapenem Sodium for Injection Industry Trends
2.2 Ertapenem Sodium for Injection Industry Drivers
2.3 Ertapenem Sodium for Injection Industry Opportunities and Challenges
2.4 Ertapenem Sodium for Injection Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Ertapenem Sodium for Injection Revenue (2020-2025)
3.2 Global Top Players by Ertapenem Sodium for Injection Sales (2020-2025)
3.3 Global Top Players by Ertapenem Sodium for Injection Price (2020-2025)
3.4 Global Ertapenem Sodium for Injection Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Ertapenem Sodium for Injection Major Company Production Sites & Headquarters
3.6 Global Ertapenem Sodium for Injection Company, Product Type & Application
3.7 Global Ertapenem Sodium for Injection Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Ertapenem Sodium for Injection Market CR5 and HHI
3.8.2 Global Top 5 and 10 Ertapenem Sodium for Injection Players Market Share by Revenue in 2024
3.8.3 2023 Ertapenem Sodium for Injection Tier 1, Tier 2, and Tier 3
4 Ertapenem Sodium for Injection Regional Status and Outlook
4.1 Global Ertapenem Sodium for Injection Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Ertapenem Sodium for Injection Historic Market Size by Region
4.2.1 Global Ertapenem Sodium for Injection Sales in Volume by Region (2020-2025)
4.2.2 Global Ertapenem Sodium for Injection Sales in Value by Region (2020-2025)
4.2.3 Global Ertapenem Sodium for Injection Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Ertapenem Sodium for Injection Forecasted Market Size by Region
4.3.1 Global Ertapenem Sodium for Injection Sales in Volume by Region (2026-2031)
4.3.2 Global Ertapenem Sodium for Injection Sales in Value by Region (2026-2031)
4.3.3 Global Ertapenem Sodium for Injection Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Ertapenem Sodium for Injection by Application
5.1 Ertapenem Sodium for Injection Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Ertapenem Sodium for Injection Market Size by Application
5.2.1 Global Ertapenem Sodium for Injection Market Size Overview by Application (2020-2031)
5.2.2 Global Ertapenem Sodium for Injection Historic Market Size Review by Application (2020-2025)
5.2.3 Global Ertapenem Sodium for Injection Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Ertapenem Sodium for Injection Sales Breakdown by Application (2020-2025)
5.3.2 Europe Ertapenem Sodium for Injection Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Ertapenem Sodium for Injection Sales Breakdown by Application (2020-2025)
5.3.4 South America Ertapenem Sodium for Injection Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Ertapenem Sodium for Injection Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
6.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Comapny Information
6.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview
6.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments
6.2 Sichuan Pharmaceutical Preparation Co., Ltd.
6.2.1 Sichuan Pharmaceutical Preparation Co., Ltd. Comapny Information
6.2.2 Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview
6.2.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.2.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments
6.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
6.3.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Comapny Information
6.3.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
6.3.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.3.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
6.4 Qilu Anti Pharmaceutical Co., Ltd.
6.4.1 Qilu Anti Pharmaceutical Co., Ltd. Comapny Information
6.4.2 Qilu Anti Pharmaceutical Co., Ltd. Business Overview
6.4.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.4.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments
6.5 Hainan Herui Pharmaceutical Co., Ltd.
6.5.1 Hainan Herui Pharmaceutical Co., Ltd. Comapny Information
6.5.2 Hainan Herui Pharmaceutical Co., Ltd. Business Overview
6.5.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.5.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments
6.6 Unitech Biotech
6.6.1 Unitech Biotech Comapny Information
6.6.2 Unitech Biotech Business Overview
6.6.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
6.6.5 Unitech Biotech Recent Developments
6.7 Par Pharmaceutical
6.7.1 Par Pharmaceutical Comapny Information
6.7.2 Par Pharmaceutical Business Overview
6.7.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
6.7.5 Par Pharmaceutical Recent Developments
6.8 NorthStar Rx
6.8.1 NorthStar Rx Comapny Information
6.8.2 NorthStar Rx Business Overview
6.8.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
6.8.5 NorthStar Rx Recent Developments
6.9 Intelicure Lifesciences
6.9.1 Intelicure Lifesciences Comapny Information
6.9.2 Intelicure Lifesciences Business Overview
6.9.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
6.9.5 Intelicure Lifesciences Recent Developments
6.10 EUGIA PHARMA INC
6.10.1 EUGIA PHARMA INC Comapny Information
6.10.2 EUGIA PHARMA INC Business Overview
6.10.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
6.10.5 EUGIA PHARMA INC Recent Developments
6.11 ACS DOBFAR SPA
6.11.1 ACS DOBFAR SPA Comapny Information
6.11.2 ACS DOBFAR SPA Business Overview
6.11.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
6.11.5 ACS DOBFAR SPA Recent Developments
7 North America by Country
7.1 North America Ertapenem Sodium for Injection Sales by Country
7.1.1 North America Ertapenem Sodium for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Ertapenem Sodium for Injection Sales by Country (2020-2025)
7.1.3 North America Ertapenem Sodium for Injection Sales Forecast by Country (2026-2031)
7.2 North America Ertapenem Sodium for Injection Market Size by Country
7.2.1 North America Ertapenem Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Ertapenem Sodium for Injection Market Size by Country (2020-2025)
7.2.3 North America Ertapenem Sodium for Injection Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Ertapenem Sodium for Injection Sales by Country
8.1.1 Europe Ertapenem Sodium for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Ertapenem Sodium for Injection Sales by Country (2020-2025)
8.1.3 Europe Ertapenem Sodium for Injection Sales Forecast by Country (2026-2031)
8.2 Europe Ertapenem Sodium for Injection Market Size by Country
8.2.1 Europe Ertapenem Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Ertapenem Sodium for Injection Market Size by Country (2020-2025)
8.2.3 Europe Ertapenem Sodium for Injection Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Ertapenem Sodium for Injection Sales by Country
9.1.1 Asia-Pacific Ertapenem Sodium for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Ertapenem Sodium for Injection Sales by Country (2020-2025)
9.1.3 Asia-Pacific Ertapenem Sodium for Injection Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Ertapenem Sodium for Injection Market Size by Country
9.2.1 Asia-Pacific Ertapenem Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Ertapenem Sodium for Injection Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Ertapenem Sodium for Injection Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Ertapenem Sodium for Injection Sales by Country
10.1.1 South America Ertapenem Sodium for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Ertapenem Sodium for Injection Sales by Country (2020-2025)
10.1.3 South America Ertapenem Sodium for Injection Sales Forecast by Country (2026-2031)
10.2 South America Ertapenem Sodium for Injection Market Size by Country
10.2.1 South America Ertapenem Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Ertapenem Sodium for Injection Market Size by Country (2020-2025)
10.2.3 South America Ertapenem Sodium for Injection Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Ertapenem Sodium for Injection Sales by Country
11.1.1 Middle East and Africa Ertapenem Sodium for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2020-2025)
11.1.3 Middle East and Africa Ertapenem Sodium for Injection Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Ertapenem Sodium for Injection Market Size by Country
11.2.1 Middle East and Africa Ertapenem Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Ertapenem Sodium for Injection Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Ertapenem Sodium for Injection Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Ertapenem Sodium for Injection Value Chain Analysis
12.1.1 Ertapenem Sodium for Injection Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Ertapenem Sodium for Injection Production Mode & Process
12.2 Ertapenem Sodium for Injection Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Ertapenem Sodium for Injection Distributors
12.2.3 Ertapenem Sodium for Injection Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.